Perbak Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,578
Closed -$1.07M 202
2024
Q4
$1.07M Buy
3,578
+1,341
+60% +$469K 0.57% 47
2024
Q3
$909K Sell
2,237
-7,086
-76% -$2.59M 0.64% 26
2024
Q2
$3M Buy
+9,323
New +$3.03M 0.89% 26

Other funds holding HCA

Perbak Capital Partners's HCA Position: Q1 2025 in Review

Perbak Capital Partners sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 3,578 shares — an estimated $1.07M sold.

Perbak Capital Partners first reported a position in HCA in Q2 2024 and held it in 3 quarters. The position peaked at $3M in Q2 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Perbak Capital Partners reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 3,578 HCA Healthcare shares in Q1 2025, an estimated $1.07M.
  • Perbak Capital Partners first reported a position in HCA Healthcare in Q2 2024 and held it in 3 quarters.
  • Perbak Capital Partners's HCA Healthcare position peaked at $3M in Q2 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Perbak Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.